SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness
COVID-19 has resulted in a pandemic after its first appearance in a pneumonia patient in China in early December 2019. As per WHO, this global outbreak of novel COVID-19 has resulted in 28,329,790 laboratory-confirmed cases and 911,877 deaths which have been reported from 210 countries as on 12th Se...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-12-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2020.606779/full |
| _version_ | 1828892028018098176 |
|---|---|
| author | Pottathil Shinu Mohamed A. Morsy Mohamed A. Morsy Pran Kishore Deb Anroop B. Nair Manoj Goyal Jigar Shah Sabna Kotta |
| author_facet | Pottathil Shinu Mohamed A. Morsy Mohamed A. Morsy Pran Kishore Deb Anroop B. Nair Manoj Goyal Jigar Shah Sabna Kotta |
| author_sort | Pottathil Shinu |
| collection | DOAJ |
| description | COVID-19 has resulted in a pandemic after its first appearance in a pneumonia patient in China in early December 2019. As per WHO, this global outbreak of novel COVID-19 has resulted in 28,329,790 laboratory-confirmed cases and 911,877 deaths which have been reported from 210 countries as on 12th Sep 2020. The major symptoms at the beginning of COVID-19 are fever (98%), tussis (76%), sore throat (17%), rhinorrhea (2%), chest pain (2%), and myalgia or fatigue (44%). Furthermore, acute respiratory distress syndrome (61.1%), cardiac dysrhythmia (44.4%), shock (30.6%), hemoptysis (5%), stroke (5%), acute cardiac injury (12%), acute kidney injury (36.6%), dermatological symptoms with maculopapular exanthema (36.1%), and death can occur in severe cases. Even though human coronavirus (CoV) is mainly responsible for the infections of the respiratory tract, some studies have shown CoV (in case of Severe Acute Respiratory Syndrome, SARS and Middle East Respiratory Syndrome, MERS) to possess potential to spread to extra-pulmonary organs including the nervous system as well as gastrointestinal tract (GIT). Patients infected with COVID-19 have also shown symptoms associated with neurological and enteric infection like disorders related to smell/taste, loss of appetite, nausea, emesis, diarrhea, and pain in the abdomen. In the present review, we attempt to evaluate the understanding of basic mechanisms involved in clinical manifestations of COVID-19, mainly focusing on interaction of COVID-19 with gut-brain axis. This review combines both biological characteristics of the virus and its clinical manifestations in order to comprehend an insight into the fundamental potential mechanisms of COVID-19 virus infection, and thus endorse in the advancement of prophylactic and treatment strategies. |
| first_indexed | 2024-12-13T13:27:29Z |
| format | Article |
| id | doaj.art-5c26477e878740bc9c8b99b6efc483d5 |
| institution | Directory Open Access Journal |
| issn | 2296-889X |
| language | English |
| last_indexed | 2024-12-13T13:27:29Z |
| publishDate | 2020-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Molecular Biosciences |
| spelling | doaj.art-5c26477e878740bc9c8b99b6efc483d52022-12-21T23:44:15ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2020-12-01710.3389/fmolb.2020.606779606779SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and IllnessPottathil Shinu0Mohamed A. Morsy1Mohamed A. Morsy2Pran Kishore Deb3Anroop B. Nair4Manoj Goyal5Jigar Shah6Sabna Kotta7Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi ArabiaDepartment of Pharmacology, Faculty of Medicine, Minia University, El-Minia, EgyptDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, JordanDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi ArabiaDepartment of Anesthesia Technology, College of Applied Medical Sciences in Jubail, Imam Abdulrahman bin Faisal University, Dammam, Saudi ArabiaDepartment of Pharmaceutics, Institute of Pharmacy, Nirma University, Ahmedabad, IndiaDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaCOVID-19 has resulted in a pandemic after its first appearance in a pneumonia patient in China in early December 2019. As per WHO, this global outbreak of novel COVID-19 has resulted in 28,329,790 laboratory-confirmed cases and 911,877 deaths which have been reported from 210 countries as on 12th Sep 2020. The major symptoms at the beginning of COVID-19 are fever (98%), tussis (76%), sore throat (17%), rhinorrhea (2%), chest pain (2%), and myalgia or fatigue (44%). Furthermore, acute respiratory distress syndrome (61.1%), cardiac dysrhythmia (44.4%), shock (30.6%), hemoptysis (5%), stroke (5%), acute cardiac injury (12%), acute kidney injury (36.6%), dermatological symptoms with maculopapular exanthema (36.1%), and death can occur in severe cases. Even though human coronavirus (CoV) is mainly responsible for the infections of the respiratory tract, some studies have shown CoV (in case of Severe Acute Respiratory Syndrome, SARS and Middle East Respiratory Syndrome, MERS) to possess potential to spread to extra-pulmonary organs including the nervous system as well as gastrointestinal tract (GIT). Patients infected with COVID-19 have also shown symptoms associated with neurological and enteric infection like disorders related to smell/taste, loss of appetite, nausea, emesis, diarrhea, and pain in the abdomen. In the present review, we attempt to evaluate the understanding of basic mechanisms involved in clinical manifestations of COVID-19, mainly focusing on interaction of COVID-19 with gut-brain axis. This review combines both biological characteristics of the virus and its clinical manifestations in order to comprehend an insight into the fundamental potential mechanisms of COVID-19 virus infection, and thus endorse in the advancement of prophylactic and treatment strategies.https://www.frontiersin.org/articles/10.3389/fmolb.2020.606779/fullSARS-CoV-2COVID-19 infectiongut-brain axisACE2 receptormicrobiotadysbiosis |
| spellingShingle | Pottathil Shinu Mohamed A. Morsy Mohamed A. Morsy Pran Kishore Deb Anroop B. Nair Manoj Goyal Jigar Shah Sabna Kotta SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness Frontiers in Molecular Biosciences SARS-CoV-2 COVID-19 infection gut-brain axis ACE2 receptor microbiota dysbiosis |
| title | SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness |
| title_full | SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness |
| title_fullStr | SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness |
| title_full_unstemmed | SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness |
| title_short | SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness |
| title_sort | sars cov 2 organotropism associated pathogenic relationship of gut brain axis and illness |
| topic | SARS-CoV-2 COVID-19 infection gut-brain axis ACE2 receptor microbiota dysbiosis |
| url | https://www.frontiersin.org/articles/10.3389/fmolb.2020.606779/full |
| work_keys_str_mv | AT pottathilshinu sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT mohamedamorsy sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT mohamedamorsy sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT prankishoredeb sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT anroopbnair sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT manojgoyal sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT jigarshah sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness AT sabnakotta sarscov2organotropismassociatedpathogenicrelationshipofgutbrainaxisandillness |